Nephros Inc
NASDAQ:NEPH

Watchlist Manager
Nephros Inc Logo
Nephros Inc
NASDAQ:NEPH
Watchlist
Price: 3.89 USD -3.23% Market Closed
Market Cap: $41.4m

Nephros Inc
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Nephros Inc
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Nephros Inc
NASDAQ:NEPH
Inventory
$2.7m
CAGR 3-Years
-8%
CAGR 5-Years
-13%
CAGR 10-Years
15%
Whirlpool Corp
NYSE:WHR
Inventory
$2.3B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
-1%
Hamilton Beach Brands Holding Co
NYSE:HBB
Inventory
$174.8m
CAGR 3-Years
-11%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Cricut Inc
NASDAQ:CRCT
Inventory
$134.9m
CAGR 3-Years
-35%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Vesync Co Ltd
HKEX:2148
Inventory
$72.6m
CAGR 3-Years
-17%
CAGR 5-Years
17%
CAGR 10-Years
N/A
S
Sharkninja Inc
NYSE:SN
Inventory
$900m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Nephros Inc
Glance View

Market Cap
41.4m USD
Industry
Consumer products

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.

NEPH Intrinsic Value
2.66 USD
Overvaluation 32%
Intrinsic Value
Price

See Also

What is Nephros Inc's Inventory?
Inventory
2.7m USD

Based on the financial report for Sep 30, 2025, Nephros Inc's Inventory amounts to 2.7m USD.

What is Nephros Inc's Inventory growth rate?
Inventory CAGR 10Y
15%

Over the last year, the Inventory growth was -12%. The average annual Inventory growth rates for Nephros Inc have been -8% over the past three years , -13% over the past five years , and 15% over the past ten years .

Back to Top